Rallybio (RLYB) Competitors

Invivyd (NASDAQ:IVVD) and Rallybio (NASDAQ:RLYB) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability, community ranking and media sentiment.

Do insiders and institutionals hold more shares of IVVD or RLYB?

70.4% of Invivyd shares are held by institutional investors. Comparatively, 90.3% of Rallybio shares are held by institutional investors. 17.9% of Invivyd shares are held by company insiders. Comparatively, 7.4% of Rallybio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Does the MarketBeat Community prefer IVVD or RLYB?

Rallybio received 21 more outperform votes than Invivyd when rated by MarketBeat users. However, 84.62% of users gave Invivyd an outperform vote while only 78.18% of users gave Rallybio an outperform vote.

Company	Underperform	Outperform
Invivyd	Outperform Votes 22 84.62%	Underperform Votes 4 15.38%
Rallybio	Outperform Votes 43 78.18%	Underperform Votes 12 21.82%

Is IVVD or RLYB more profitable?

Rallybio's return on equity of -77.39% beat Invivyd's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Invivyd	N/A	-155.33%	-114.88%
Rallybio	N/A	-77.39%	-69.33%

Which has more volatility & risk, IVVD or RLYB?

Invivyd has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Comparatively, Rallybio has a beta of -1.45, indicating that its share price is 245% less volatile than the S&P 500.

Does the media refer more to IVVD or RLYB?

In the previous week, Rallybio had 1 more articles in the media than Invivyd. MarketBeat recorded 4 mentions for Rallybio and 3 mentions for Invivyd. Rallybio's average media sentiment score of 1.87 beat Invivyd's score of 0.62 indicating that Rallybio is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Invivyd	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rallybio	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts rate IVVD or RLYB?

Invivyd currently has a consensus price target of $7.89, indicating a potential upside of 871.25%. Rallybio has a consensus price target of $9.75, indicating a potential upside of 1,386.28%. Given Rallybio's higher possible upside, analysts plainly believe Rallybio is more favorable than Invivyd.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Invivyd	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20
Rallybio	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Which has better valuation & earnings, IVVD or RLYB?

Rallybio has lower revenue, but higher earnings than Invivyd. Invivyd is trading at a lower price-to-earnings ratio than Rallybio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Invivyd	$11.56M	8.40	-$198.64M	-$1.96	-0.41
Rallybio	$598K	45.51	-$74.56M	-$1.60	-0.41

Summary

Rallybio beats Invivyd on 11 of the 17 factors compared between the two stocks.